Avian Tuberculosis (Mycobacterium avium)

Avian tuberculosis is a chronic, contagious, and typically fatal bacterial disease of poultry and other birds caused by Mycobacterium avium, primarily the serotypes belonging to M. avium subsp. avium (MAA). It is characterized by the formation of granulomatous lesions (tubercles) in the liver, spleen, intestines, and bone marrow, leading to progressive emaciation, decreased egg production, and high mortality over months. The disease is of significant economic importance in commercial layers, breeder flocks, and backyard poultry, particularly in older birds, due to its chronic nature and the lack of effective treatment. In commercial broilers, the disease is rare due to their short lifespan, but it can occur in breeder flocks and free-range systems. The disease is zoonotic, especially in immunocompromised humans, and is a reportable disease in many countries, necessitating depopulation and strict biosecurity measures.

The primary causative agent is Mycobacterium avium subsp. avium (MAA), a member of the Mycobacterium avium complex (MAC). MAA is an acid-fast, aerobic, non-motile, non-spore-forming bacillus. It is characterized by its slow growth (taking 2-6 weeks on selective media such as Lowenstein-Jensen or Middlebrook 7H10 agar), and its ability to survive in the environment for long periods, especially in soil and litter. The cell wall contains complex lipids, including mycolic acids, which contribute to its acid-fastness and resistance to disinfectants. Serotypes 1, 2, and 3 are most commonly associated with avian tuberculosis, with serotype 1 being the most prevalent in poultry. M. avium subsp. hominissuis (MAH) can also cause disease in birds but is more commonly associated with human infections. The organism is an intracellular pathogen that primarily infects macrophages, where it survives and multiplies within phagosomes, avoiding lysosomal fusion. This intracellular survival is mediated by the production of cord factor (trehalose 6,6'-dimycolate) and other virulence factors that inhibit macrophage activation.

Avian tuberculosis is most prevalent in adult poultry, particularly in commercial layers and breeder flocks, where the chronic nature of the disease allows for gradual spread within the flock. The disease is rare in broilers due to their short lifespan (6-8 weeks), but can occur in free-range or organic broiler systems where birds are kept longer. The incidence is higher in deep litter and free-range housing systems compared to cage systems, as the organism persists in the litter and soil. The disease is more common in temperate climates and can be exacerbated by poor biosecurity, high stocking density, and co-infections with immunosuppressive agents such as Marek's disease virus or infectious bursal disease virus. Morbidity in affected flocks can be as high as 10-20%, with mortality reaching 50-100% over several months. Egg production can drop by 10-30%, and feed conversion ratio (FCR) may increase by 0.2-0.5 due to chronic wasting. The disease is transmitted primarily through the fecal-oral route, with birds ingesting contaminated feed, water, or litter. Wild birds, rodents, and other animals can serve as mechanical vectors. Vertical transmission via eggs is rare but possible. The organism can survive in the environment for up to 4 years in contaminated soil, making eradication difficult.

After ingestion, M. avium is taken up by macrophages in the intestinal mucosa, particularly in the ileum and ceca. The bacteria survive within macrophages by inhibiting phagosome-lysosome fusion and acidification. Infected macrophages migrate to regional lymph nodes (cecal tonsils) and then disseminate via the bloodstream to the liver, spleen, and bone marrow. The host immune response, primarily cell-mediated immunity, leads to the formation of granulomas (tubercles) consisting of a central caseous necrosis surrounded by epithelioid macrophages, multinucleated giant cells, and a fibrous capsule. As the disease progresses, the granulomas enlarge and coalesce, causing organ dysfunction. In the liver and spleen, extensive granulomatous infiltration leads to hepatomegaly and splenomegaly, with the organs becoming friable and covered with grayish-white nodules. In the intestine, granulomas can cause mucosal ulceration and malabsorption, leading to chronic diarrhea and emaciation. The bone marrow may also be affected, leading to anemia and immunosuppression. The chronic inflammatory response results in cachexia, with severe muscle wasting and depletion of fat stores. The disease is slowly progressive, with clinical signs appearing months after initial infection.

Intrinsic factors include age (older birds are more susceptible due to longer exposure and waning immunity), genetic susceptibility (some breeds may be more resistant), and immunosuppression (due to concurrent infections like Marek's disease, infectious bursal disease, or mycotoxins). High production stress in layers and breeders can also increase susceptibility. Extrinsic factors include poor biosecurity (allowing introduction of infected birds or contaminated equipment), high stocking density (increasing fecal-oral transmission), inadequate cleaning and disinfection (allowing environmental persistence), contaminated litter or soil (especially in free-range systems), and poor ventilation (leading to ammonia accumulation and respiratory irritation). Additionally, feeding contaminated feed or water, and the presence of wild birds or rodents that can carry the organism, are significant risk factors.

Clinical signs are often insidious and may not be apparent until the disease is advanced. Affected birds show progressive weight loss (emaciation) despite a normal appetite, decreased activity, and depression. The comb and wattles become pale and shrunken. Diarrhea may be present, with feces being watery and sometimes containing blood. Egg production declines significantly, and affected hens may stop laying altogether. In advanced cases, birds may develop lameness due to bone marrow involvement or joint lesions. Respiratory signs are uncommon but can occur if the lungs are affected. Mortality is gradual, with birds dying from cachexia or secondary infections. In some cases, sudden death may occur due to rupture of an enlarged liver or spleen. The disease is chronic, with clinical signs developing over weeks to months.

Differential diagnoses include: 1) Colibacillosis (Escherichia coli infection) - causes peritonitis, airsacculitis, and septicemia, but lesions are fibrinous rather than granulomatous, and acid-fast staining is negative. 2) Salmonellosis (fowl typhoid and pullorum disease) - causes acute septicemia with necrotic foci in liver and spleen, but lesions are not granulomatous, and the disease is more acute. 3) Mycobacteriosis caused by other mycobacteria (e.g., M. genavense) - similar lesions but can be differentiated by PCR or culture. 4) Lymphoid leukosis (avian leukosis virus) - causes tumors in liver and spleen, but histopathology shows lymphoblastic infiltration, not granulomas. 5) Marek's disease - causes lymphomas in viscera and nerves, but lesions are not granulomatous. 6) Coccidiosis - causes intestinal lesions, but they are primarily in the ceca and are hemorrhagic, not granulomatous. 7) Histomoniasis (blackhead) - causes cecal cores and liver lesions, but the liver lesions are circular, depressed, and not granulomatous. 8) Aspergillosis - causes granulomatous lesions in lungs and air sacs, but they are typically in the respiratory tract, and fungal hyphae are visible on histopathology. 9) Fatty liver hemorrhagic syndrome - causes liver enlargement and hemorrhage, but no granulomas. 10) Vitamin E/selenium deficiency - causes muscular dystrophy and encephalomalacia, but no granulomas. Definitive diagnosis is based on acid-fast staining of lesions, culture, or PCR.

The diagnostic approach begins with a thorough flock history, including age, mortality pattern, and clinical signs. On post-mortem examination, the presence of grayish-white nodules in the liver, spleen, and intestines is highly suggestive. Impression smears from these lesions should be stained with Ziehl-Neelsen (acid-fast) stain to demonstrate acid-fast bacilli. Confirmatory tests include: 1) Bacterial culture on Lowenstein-Jensen or Middlebrook 7H10 media, which may take 2-6 weeks. 2) PCR targeting the IS1245 or IS901 insertion sequences for M. avium subsp. avium. 3) Histopathology of affected tissues showing granulomas with central caseation and acid-fast bacilli. 4) Serological tests such as the rapid agglutination test or ELISA for detection of antibodies, but these are less sensitive and specific. 5) Intradermal tuberculin test using avian tuberculin, but this is not commonly used in poultry. The diagnostic algorithm should also include differential testing for other causes of granulomatous lesions, such as fungal infections. In live birds, diagnosis is difficult, but PCR on fecal samples or tracheal swabs may be attempted. However, due to the chronic nature and public health implications, depopulation is often recommended without extensive diagnostic testing.

Serology: ELISA for M. avium antibodies may show elevated titers, but sensitivity is low. The rapid agglutination test using whole blood or serum can be used, but false positives occur. Molecular diagnostics: PCR for IS1245 or IS901 is highly sensitive and specific. Microbiology: Culture on selective media yields slow-growing, acid-fast bacilli. Blood chemistry: Affected birds may show anemia (decreased hematocrit), elevated liver enzymes (AST, LDH), and decreased total protein due to malabsorption. CBC may show leukocytosis with monocytosis. Histopathology: Granulomas with central caseous necrosis, epithelioid macrophages, Langhans giant cells, and fibrous capsule. Acid-fast staining reveals numerous red bacilli within macrophages and necrotic areas.

Radiography is not commonly used in poultry, but in advanced cases, hepatomegaly and splenomegaly may be visible. Ultrasonography can be used to detect organomegaly and nodular lesions in the liver and spleen. Gross necropsy photography is essential for documentation, showing characteristic grayish-white nodules on the surface and cut surface of the liver, spleen, and intestinal wall. The nodules are often caseous and may be calcified in chronic cases.

Gross necropsy findings: The liver and spleen are enlarged and studded with multiple, small (1-5 mm) grayish-white to yellowish nodules. The nodules may coalesce to form larger masses. The intestinal wall, especially the ileum and ceca, may show similar nodules, and the mucosa may be ulcerated. The bone marrow may be replaced by granulomatous tissue. Histopathology: The nodules are granulomas with a central area of caseous necrosis, surrounded by a zone of epithelioid macrophages, multinucleated giant cells (Langhans type), and lymphocytes. The periphery is encapsulated by fibrous connective tissue. Acid-fast staining (Ziehl-Neelsen) demonstrates numerous acid-fast bacilli within the necrotic center and macrophages. In early lesions, the granulomas are non-encapsulated and consist mainly of macrophages. Calcification may be present in chronic lesions.

There is no effective treatment for avian tuberculosis in poultry. Antimicrobial therapy with drugs such as isoniazid, rifampicin, ethambutol, or streptomycin is not practical or economically feasible in commercial flocks, and the disease is considered incurable. The recommended approach is depopulation of the affected flock, followed by thorough cleaning and disinfection of the premises. In some countries, the disease is reportable, and regulatory authorities may mandate depopulation. For valuable breeding stock, isolation and culling of positive birds may be attempted, but this is rarely successful due to the chronic nature and environmental contamination. Supportive therapy with vitamins and electrolytes may be given to reduce stress, but it does not alter the outcome. Vaccination is not available for avian tuberculosis. Biosecurity measures, including rodent control and preventing contact with wild birds, are essential to prevent introduction and spread.

The prognosis for affected flocks is poor. The disease is chronic and progressive, with mortality eventually reaching 100% if left unchecked. Even with depopulation and repopulation, the organism can persist in the environment for years, leading to recurrence. Egg production in affected flocks may never return to normal, and the economic losses are significant. In individual birds, the prognosis is grave, and they should be culled. The zoonotic risk to humans, especially immunocompromised individuals, is a serious concern, and affected flocks should be handled with caution.

After depopulation, the premises should be thoroughly cleaned and disinfected. All litter and manure should be removed and disposed of properly. The house should be washed with detergent and then disinfected with a product effective against mycobacteria, such as phenolic compounds, cresylic acid, or formaldehyde. The soil in free-range areas may need to be removed or treated. A downtime of at least 6-12 months is recommended before restocking. Sentinel birds (e.g., specific-pathogen-free chickens) can be placed on the premises to monitor for residual contamination. Regular monitoring of the flock for clinical signs and post-mortem examination of any dead birds is essential. Biosecurity protocols should be reviewed and strengthened to prevent re-introduction.

Pearls: 1) Avian tuberculosis should be suspected in adult birds with chronic wasting and granulomatous lesions in the liver and spleen. 2) Acid-fast staining of impression smears is a rapid and inexpensive diagnostic tool. 3) The disease is zoonotic, so wear gloves and masks during necropsy. 4) The organism is highly resistant to environmental degradation, so thorough cleaning and disinfection are critical. Pitfalls: 1) Confusing tuberculosis with other causes of granulomatous lesions, such as aspergillosis or coligranuloma (Hjarre's disease). 2) Relying on serology alone, as false negatives are common. 3) Attempting to treat the disease with antibiotics, which is ineffective and may lead to antimicrobial resistance. 4) Failing to report the disease to regulatory authorities, leading to public health risks.

There are no approved drug protocols for the treatment of avian tuberculosis in poultry. Antimicrobials such as isoniazid (10-20 mg/kg orally twice daily), rifampicin (10-20 mg/kg orally once daily), and ethambutol (15-25 mg/kg orally once daily) have been used in individual pet birds, but they are not effective in eradicating the infection and are not approved for food-producing birds. In commercial flocks, treatment is not recommended. Supportive care with vitamins (e.g., vitamin A, D3, E, and B-complex) and electrolytes in drinking water may be given to reduce stress, but they do not affect the disease outcome. Vaccination is not available. Biosecurity and depopulation are the only effective control measures.

Avian tuberculosis is a well-documented disease in poultry literature. Key references include: 1) Diseases of Poultry (Swayne et al., 2020) provides a comprehensive review of the etiology, pathogenesis, and control. 2) The Avian Disease Manual (AAAP, 2019) offers practical diagnostic and control guidelines. 3) Studies by Thoen et al. (2006) and Dhama et al. (2011) have reviewed the epidemiology and zoonotic potential of M. avium. 4) Research by Tell et al. (2001) has evaluated diagnostic methods, including PCR. 5) The World Organisation for Animal Health (WOAH) lists avian tuberculosis as a notifiable disease, and its Terrestrial Manual provides standardized diagnostic protocols. 6) A study by Cromie et al. (1991) on pheasants highlighted the importance of environmental contamination. 7) Recent molecular studies have focused on the genetic diversity of M. avium strains and their host specificity. Overall, the consensus is that depopulation is the most effective control measure, and biosecurity is essential to prevent introduction.